Seeking Alpha

Salix Pharmaceuticals (SLXP): Q4 EPS of -$0.13 beats by $0.01. Revenue of $70M (+15.8%) vs....

Salix Pharmaceuticals (SLXP): Q4 EPS of -$0.13 beats by $0.01. Revenue of $70M (+15.8%) vs. $68M. Guides Q1 EPS, revenue below consensus. Shares -3.2% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)